BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22885124)

  • 1. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
    Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
    Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megakaryocyte lineage development is controlled by modulation of protein acetylation.
    Bartels M; Govers A; Polak R; Vervoort S; van Boxtel R; Pals C; Bierings M; van Solinge W; Egberts T; Nieuwenhuis E; Mokry M; Coffer PJ
    PLoS One; 2018; 13(4):e0196400. PubMed ID: 29698469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid regulates erythro-megakaryocytic differentiation through the modulation of transcription factors and microRNA regulatory micro-networks.
    Trécul A; Morceau F; Gaigneaux A; Schnekenburger M; Dicato M; Diederich M
    Biochem Pharmacol; 2014 Nov; 92(2):299-311. PubMed ID: 25241289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis.
    Liu B; Ohishi K; Yamamura K; Suzuki K; Monma F; Ino K; Nishii K; Masuya M; Sekine T; Heike Y; Takaue Y; Katayama N
    Exp Hematol; 2010 Aug; 38(8):685-95. PubMed ID: 20381581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation.
    Lulli V; Romania P; Morsilli O; Gabbianelli M; Pagliuca A; Mazzeo S; Testa U; Peschle C; Marziali G
    Cell Death Differ; 2006 Jul; 13(7):1064-74. PubMed ID: 16294212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF.
    Bianchi E; Bulgarelli J; Ruberti S; Rontauroli S; Sacchi G; Norfo R; Pennucci V; Zini R; Salati S; Prudente Z; Ferrari S; Manfredini R
    Cell Death Differ; 2015 Dec; 22(12):1906-21. PubMed ID: 25857263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDDO-Im is a stimulator of megakaryocytic differentiation.
    Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U
    Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway.
    Chateauvieux S; Eifes S; Morceau F; Grigorakaki C; Schnekenburger M; Henry E; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Feb; 81(4):498-509. PubMed ID: 21108933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation.
    Yu IT; Park JY; Kim SH; Lee JS; Kim YS; Son H
    Neuropharmacology; 2009 Feb; 56(2):473-80. PubMed ID: 19007798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.
    Kokorina NA; Granier CJ; Zakharkin SO; Davis S; Rabson AB; Sabaawy HE
    Exp Hematol; 2012 Dec; 40(12):1028-1042.e3. PubMed ID: 22922207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.
    Kiani A; Habermann I; Haase M; Feldmann S; Boxberger S; Sanchez-Fernandez MA; Thiede C; Bornhäuser M; Ehninger G
    J Leukoc Biol; 2004 Nov; 76(5):1057-65. PubMed ID: 15292278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells.
    Salati S; Zini R; Bianchi E; Testa A; Mavilio F; Manfredini R; Ferrari S
    Stem Cells; 2008 Apr; 26(4):950-9. PubMed ID: 18192237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEIS1 regulates early erythroid and megakaryocytic cell fate.
    Zeddies S; Jansen SB; di Summa F; Geerts D; Zwaginga JJ; van der Schoot CE; von Lindern M; Thijssen-Timmer DC
    Haematologica; 2014 Oct; 99(10):1555-64. PubMed ID: 25107888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
    Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
    Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential transcriptional regulation of meis1 by Gfi1b and its co-factors LSD1 and CoREST.
    Chowdhury AH; Ramroop JR; Upadhyay G; Sengupta A; Andrzejczyk A; Saleque S
    PLoS One; 2013; 8(1):e53666. PubMed ID: 23308270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers.
    Vulcano F; Ciccarelli C; Mattia G; Marampon F; Giampiero M; Milazzo L; Pascuccio M; Zani BM; Giampaolo A; Hassan HJ
    Exp Cell Res; 2006 May; 312(9):1590-7. PubMed ID: 16739251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1.
    Zini R; Rossi C; Norfo R; Pennucci V; Barbieri G; Ruberti S; Rontauroli S; Salati S; Bianchi E; Manfredini R
    Stem Cells Dev; 2016 Oct; 25(19):1433-43. PubMed ID: 27520398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.
    Ma D; Sun Y; Lin D; Wang H; Dai B; Zhang X; Ouyang W; Jian J; Jia W; Xu X; Jin B
    Eur J Haematol; 2005 Mar; 74(3):228-40. PubMed ID: 15693793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDDO-Im, an antitumor molecule that also improves platetet production.
    Sardina JL; López-Ruano G; Sánchez-Sánchez B; Hernández-Hernández A
    Leuk Res; 2011 Apr; 35(4):427-8. PubMed ID: 21074266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.